Aequim Alternative Investments LP Invitae Corp Transaction History

Aequim Alternative Investments LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$26.09 - $40.4 $4.97 Million - $7.7 Million	-190,600 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$33.06 - $56.93 $4.72 Million - $8.14 Million	142,900 Added 299.58%	190,600 $7.28 Million
Q4 2020 Feb 16, 2021	SELL	$39.09 - $57.4 $2.32 Million - $3.41 Million	-59,470 Reduced 55.49%	47,700 $1.99 Million
Q4 2020 Feb 10, 2021	SELL	$39.09 - $57.4 $345,164 - $506,842	-8,830 Reduced 7.61%	107,170 $2.02 Million
Q1 2020 May 15, 2020	BUY	$7.64 - $27.5 $283,444 - $1.02 Million	37,100 Added 47.02%	116,000 $1.59 Million

Q4 2019 Feb 14, 2020	BUY	$15.02 - $20.57 $1.19 Million - $1.62 Million	78,900 New	78,900 $1.27 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Aequim Alternative Investments LP, based on Form 13F filings with the SEC.

Stay updated on Aequim Alternative Investments LP with notifications on news.